HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of low-dose dopamine infusion on cardiopulmonary and renal status in premature newborns with respiratory distress syndrome.

Abstract
To study the effects of infusion of low doses of dopamine hydrochloride on cardiopulmonary and renal status in premature newborns with respiratory distress syndrome, 49 newborns were randomly assigned to three groups: group 1 (18 patients) received no dopamine and was the control group; group 2 (16 patients) was infused with a dose of dopamine measuring 1.0 micrograms/kg of body weight per minute for 72 hours; and group 3 (15 patients) was infused with a dose of dopamine measuring 2.5 micrograms/kg of body weight per minute for 72 hours. Birth weights, gestational ages, post-natal ages, and cardiopulmonary status of all groups at the start of the study were comparable. Continuous infusion of these low doses of dopamine for 3 days after birth did not significantly improve levels of blood gases, acid-base balance, or clinical outcome. In newborns with systemic hypotension, dopamine improved cardiovascular status and caused early return of blood pressure to the normal range. Infusion of low doses of dopamine produced mild to moderate natriuresis and insignificant increases in glomerular filtration rate and urine volume.
AuthorsL Cuevas, T F Yeh, E G John, D Cuevas, R S Plides
JournalAmerican journal of diseases of children (1960) (Am J Dis Child) Vol. 145 Issue 7 Pg. 799-803 (Jul 1991) ISSN: 0002-922X [Print] United States
PMID2058612 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Dopamine
Topics
  • Acid-Base Equilibrium (drug effects)
  • Blood Gas Analysis
  • Blood Pressure (drug effects)
  • Dopamine (administration & dosage)
  • Glomerular Filtration Rate (drug effects)
  • Humans
  • Infant, Newborn
  • Infusions, Intravenous
  • Natriuresis (physiology)
  • Prospective Studies
  • Respiratory Distress Syndrome, Newborn (drug therapy, mortality, physiopathology)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: